Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug commercialization, new …
6 months, 3 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
In today’s Pharmaceutical Executive Daily, we cover market reaction to Novo Nordisk’s recent board shake-up, MJH Life Sciences’ acquisition of BPD He…
6 months, 3 weeks ago
Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up
In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to reject a petition calli…
6 months, 4 weeks ago
Pharmaceutical Executive Daily: Merck's $70 Billion Investment
In today’s Pharmaceutical Executive Daily, we cover Merck’s $70 billion expansion of U.S. operations, the FDA’s latest approvals for Novo Nordisk’s R…
6 months, 4 weeks ago
Pharmaceutical Executive Daily: FDA's National Priority Voucher Program
In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market reaction to President T…
7 months ago
Shifting Focus in Autoimmune Diseases
Artax Biopharma’s CEO Rob Armstrong explains recent shifts in autoimmune R&D before discussing his leadership style.
7 months ago
Pharmaceutical Executive Daily: EMD Serono’s Agreement with US Government
In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology into autoimmune diseases,…
7 months ago
Pharmaceutical Executive Daily: Rethinking Workforce Development
In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the executive level, the industry’s …
7 months ago
Pharmaceutical Executive Daily: Johnson & Johnson Separating Its Orthopedics Unit
In today’s Pharmaceutical Executive Daily, we explore Johnson & Johnson’s plan to separate its orthopaedics division into a standalone company, the g…
7 months ago
Pharmaceutical Executive Daily: Direct-To-Consumer Trends
In today’s Pharmaceutical Executive Daily, we cover Takeda’s new multi-year research collaboration with Nabla Bio, how tariff and pricing pressures a…
7 months ago